Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-9-30
|
pubmed:abstractText |
The prevalence of antibodies to the hepatitis C virus (HCV) was determined in 333 peritoneal dialysis (PD) patients from 10 German dialysis units, using an enzyme-linked immunosorbent assay of the second generation (ELISA 2nd gen) which detects antibodies to a structural (C22) and to non-structural (C33c, C100, 5-1-1) recombinant antigens of HCV. Sera from 18/333 (5.4%) patients were anti-HCV positive versus 11/295 (3.7%) when the sera were tested by an ELISA of the first generation (ELISA 1st gen) containing only a nonstructural antigen (C100). In the 18 sera positive by ELISA 2nd gen, antibodies against at least one viral protein were found by recombinant immunoblot assay (RIBA) in 15/333 (4.5%) patients. In the sera of 11/15 (73.3%) patients HCV RNA was detected by nested PCR. Epidemiological evaluation of the patients revealed that the prevalence of anti-HCV was correlated to the female sex (p = 0.005), presence of anti-HBc (p = 0.006), duration of total dialysis (hemodialysis HD and PD) (p = 0.012), duration of HD alone (p = 0.025) and previous renal transplantation (p < 0.001). Only a weak correlation was found to blood transfusions (p = 0.041) and elevation of serum ALT concentration (p = 0.055). But no correlation was found to diagnoses of renal failure (p = 0.129), duration of PD (p = 0.963) and past surgical procedures (p = 1.0). Four of nine peritoneal dialysates of anti-HCV positive patients were found positive for HCV RNA.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0301-0430
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
46-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7689431-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:7689431-Female,
pubmed-meshheading:7689431-Hepacivirus,
pubmed-meshheading:7689431-Hepatitis Antibodies,
pubmed-meshheading:7689431-Hepatitis C,
pubmed-meshheading:7689431-Hepatitis C Antibodies,
pubmed-meshheading:7689431-Humans,
pubmed-meshheading:7689431-Immunoblotting,
pubmed-meshheading:7689431-Kidney Failure, Chronic,
pubmed-meshheading:7689431-Male,
pubmed-meshheading:7689431-Middle Aged,
pubmed-meshheading:7689431-Peritoneal Dialysis,
pubmed-meshheading:7689431-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:7689431-Polymerase Chain Reaction,
pubmed-meshheading:7689431-Prevalence,
pubmed-meshheading:7689431-Risk Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
|
pubmed:affiliation |
Department of Internal Medicine II, Technical University of Aachen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|